CLINICAL_TRIALS
trial_result
· 2010-02-02
Clinical Trial Update: ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020) [Phase 4]
Summary
Phase 4 safety study of ZOSTAVAX in adults aged 60 and older has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 4 | Status: COMPLETED | Results posted: 2010-02-02